Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Eric Hendrickson advises clients on strategic licensing, partnering, supply, distribution, services, and other commercial arrangements, with a particular focus on such matters for life sciences clients. He also regularly represents clients in a range of industries in the IP, licensing, and commercial aspects of mergers, acquisitions, and divestitures.

  • Boehringer Ingelheim in drafting and negotiating the licenses for, and handling other IP aspects of, the mandated divestitures of certain animal vaccine and pharmaceutical products in connection with Boehringer’s acquisition of Merial.
  • A Fortune 100 company in the IP and technology aspects of its acquisition of a technology start-up for approximately $125 million.
  • A major healthcare company in drafting and negotiating the licensing, manufacturing, and supply arrangements for the divestiture of a suite of spinal medical device products.